Denosumab versus romosozumab for postmenopausal osteoporosis treatment
2021 · Scientific Reports · 87 citations
https://doi.org/10.1038/s41598-021-91248-6
Y
Yukio Nakamura
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
543
Papers
8.8K
Citations
49
h-index
194
i10-index
Yukio Nakamura is an academic researcher from Aichi Medical University. The author has contributed to research in topics: Magnetic confinement fusion research & Fusion materials and technologies & Bone health and osteoporosis research. The author has an h-index of 49, co-authored 462 publications.
Papers by this author
worksSignificant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
2016 · Osteoporosis International · 49 citations
https://doi.org/10.1007/s00198-016-3764-7
Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study
2021 · Bone Reports · 45 citations
https://doi.org/10.1016/j.bonr.2021.101068
Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment
2017 · Bone Research · 44 citations
https://doi.org/10.1038/boneres.2017.21
Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study
2015 · BMC Endocrine Disorders · 31 citations
https://doi.org/10.1186/s12902-015-0077-3
Associations of self-reported height loss and kyphosis with vertebral fractures in Japanese women 60 years and older: a cross-sectional survey
2016 · Scientific Reports · 29 citations
https://doi.org/10.1038/srep29199
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat